James E Dentzer
CIK 1400977 · President & CEO · last filed 2026-07-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$58.8K
Companies
4
Total Filings
55
Lifetime Open-Market Net
-$92.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRIS | President & CEO | 7,436 | $4.83 | $35.9K | -$92.4K | 19 | 2026-07-09 |
| IMNN | Director | 14,963 | $1.53 | $22.9K | $0 | 9 | 2026-05-27 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Chief Financial Officer | — | $38.22 | — | $0 | 1 | 2015-01-13 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Chief Financial Officer | 32,075 | $14.49 | $464.8K | $0 | 26 | 2009-10-01 |
Recent Filings · Page 6 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-02-07 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-02-05 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −220 | -$2.3K | EDGAR |
| 2008-01-23 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −660 | -$9.2K | EDGAR |
| 2008-01-23 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −2,645 | -$45.2K | EDGAR |
| 2007-10-03 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −2,500 | -$43.4K | EDGAR |
Showing 51–55 of 55
Prev
Page 6 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.